Article
[Retreatment with interferon plus ribavirin in chronic hepatitis C patients with genotype 1 who had no response or a relapse with a previous interferon treatment. Long term follow-up].
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia - 1 Sept 2002
Olaso V, Córdoba J, Molina J M, López L, Siles M S, Jaén J, Martínez F, Calvo F, Garijo R, Gobernado M
Abstract excerpt
The aims of this study were twofold: i) to evaluate the sustained response rate at 6 months, at 12 months and at the end of the follow-up [(46.39 +/- 9.74 months) (range: 6-60 months)] in patients with chronic hepatitis C retreated with interferon-a (IFN-a) plus ribavirin for 6 months (group A), 12 months (group B), in patients with relapse and those with no response to a previous course of monotherapy with...
Topics
- Adult
- Antiviral Agents
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepatitis C, Chronic
- Humans
- Interferon alpha-2
- Interferon-alpha
- Male
- Prospective Studies
- Recombinant Proteins